Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 30, 2023
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
Wed, March 29, 2023
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
[ Wed, Mar 29th 2023
] - WOPRAI
Joon Lee Maintained (VKTX) at Strong Buy with Increased Target to $32 on, Mar 29th, 2023
Joon Lee of Truist Securities, Maintained "Viking Therapeutics, Inc." (VKTX) at Strong Buy with Increased Target from $28 to $32 on, Mar 29th, 2023.
Joon has made no other calls on VKTX in the last 4 months.
There are 4 other peers that have a rating on VKTX. Out of the 4 peers that are also analyzing VKTX, 0 agree with Joon's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Joon
- Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $25 on, Tuesday, March 28th, 2023
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $30 on, Tuesday, March 28th, 2023
- Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $21 on, Thursday, February 9th, 2023
- Naz Rahman of "Maxim Group" Maintained at Strong Buy with Increased Target to $15 on, Tuesday, December 20th, 2022
